-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Compass Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2025.
- Compass Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$19.9M, a 52% decline year-over-year.
- Compass Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$62M, a 31.3% decline year-over-year.
- Compass Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$49.4M, a 16.2% decline from 2023.
- Compass Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$42.5M, a 8.33% decline from 2022.
- Compass Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$39.2M, a 52.3% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)